isoleucine has been researched along with Memory Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, YW; Kim, DK; Lim, JG; Motamedi, GK; Yi, SD | 1 |
Alkam, T; Furukawa-Hibi, Y; Mizoguchi, H; Nabeshima, T; Nitta, A; Niwa, M; Yamada, K | 1 |
2 other study(ies) available for isoleucine and Memory Disorders
Article | Year |
---|---|
Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor.
Topics: Adult; Alleles; Amino Acid Substitution; Chromosome Aberrations; Codon; Diagnosis, Differential; DNA Mutational Analysis; Epilepsy, Frontal Lobe; Female; Frontal Lobe; Genes, Dominant; Genetic Carrier Screening; Genetic Testing; Gyrus Cinguli; Humans; Isoleucine; Membrane Proteins; Memory Disorders; Methionine; Middle Aged; Mutation, Missense; Neuropsychological Tests; Nocturnal Paroxysmal Dystonia; Pedigree; Phenotype; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Polysomnography; Receptors, Nicotinic; Regional Blood Flow; Video Recording | 2008 |
Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase.
Topics: Administration, Oral; Aminoacetonitrile; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hippocampus; Isoleucine; Leucine; Male; Memory Disorders; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Oligopeptides; Peptide Fragments; Phosphorylation; Recognition, Psychology; Time Factors | 2010 |